Shirou Mohri

2.5k total citations
92 papers, 1.9k citations indexed

About

Shirou Mohri is a scholar working on Molecular Biology, Neurology and Nutrition and Dietetics. According to data from OpenAlex, Shirou Mohri has authored 92 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 40 papers in Neurology and 33 papers in Nutrition and Dietetics. Recurrent topics in Shirou Mohri's work include Prion Diseases and Protein Misfolding (82 papers), Neurological diseases and metabolism (40 papers) and Trace Elements in Health (33 papers). Shirou Mohri is often cited by papers focused on Prion Diseases and Protein Misfolding (82 papers), Neurological diseases and metabolism (40 papers) and Trace Elements in Health (33 papers). Shirou Mohri collaborates with scholars based in Japan, United Kingdom and United States. Shirou Mohri's co-authors include Tetsuyuki Kitamoto, Takashi Yokoyama, Atsushi Kobayashi, Yuichi Matsuura, Yuichi Murayama, Yoshifumi Iwamaru, Morikazu Imamura, James W. Ironside, Kentaro Masujin and Miyako Yoshioka and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Virology.

In The Last Decade

Shirou Mohri

92 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shirou Mohri Japan 26 1.7k 780 524 97 93 92 1.9k
Suehiro Sakaguchi Japan 23 1.7k 1.0× 916 1.2× 718 1.4× 62 0.6× 84 0.9× 70 1.9k
Lorenzo González United Kingdom 28 1.5k 0.9× 716 0.9× 639 1.2× 55 0.6× 60 0.6× 57 2.1k
Moira E. Bruce United Kingdom 29 2.8k 1.7× 1.2k 1.6× 1.1k 2.2× 157 1.6× 94 1.0× 44 3.0k
Mark D. Zabel United States 23 1.4k 0.9× 618 0.8× 296 0.6× 55 0.6× 38 0.4× 47 1.9k
H. Diringer Germany 26 2.8k 1.7× 1.3k 1.7× 1.3k 2.4× 193 2.0× 149 1.6× 56 3.0k
Richard F. Marsh United States 29 3.0k 1.8× 1.5k 2.0× 1.3k 2.4× 139 1.4× 149 1.6× 66 3.3k
Michael B. Coulthart Canada 19 849 0.5× 289 0.4× 162 0.3× 106 1.1× 60 0.6× 45 1.2k
Peter C. Hoppe United States 22 1.6k 1.0× 436 0.6× 359 0.7× 32 0.3× 25 0.3× 37 2.5k
Richard S. Stewart United States 14 670 0.4× 411 0.5× 257 0.5× 21 0.2× 47 0.5× 19 878
R.H. Kimberlin United States 33 3.7k 2.2× 1.6k 2.0× 1.8k 3.4× 146 1.5× 184 2.0× 70 3.8k

Countries citing papers authored by Shirou Mohri

Since Specialization
Citations

This map shows the geographic impact of Shirou Mohri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirou Mohri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirou Mohri more than expected).

Fields of papers citing papers by Shirou Mohri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shirou Mohri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirou Mohri. The network helps show where Shirou Mohri may publish in the future.

Co-authorship network of co-authors of Shirou Mohri

This figure shows the co-authorship network connecting the top 25 collaborators of Shirou Mohri. A scholar is included among the top collaborators of Shirou Mohri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shirou Mohri. Shirou Mohri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takeuchi, Atsuko, Shirou Mohri, Akira Tamaoka, et al.. (2019). Two distinct prions in fatal familial insomnia and its sporadic form. Brain Communications. 1(1). fcz045–fcz045. 12 indexed citations
2.
Kobayashi, Atsushi, Yasushi Iwasaki, Masaki Takao, et al.. (2019). A Novel Combination of Prion Strain Co-Occurrence in Patients with Sporadic Creutzfeldt-Jakob Disease. American Journal Of Pathology. 189(6). 1276–1283. 8 indexed citations
3.
Imamura, Morikazu, Nobuko Kato, Yoshifumi Iwamaru, et al.. (2016). Multiple affinity purification of a baculovirus-derived recombinant prion protein with in vitro ability to convert to its pathogenic form. Preparative Biochemistry & Biotechnology. 47(1). 1–7. 3 indexed citations
4.
Masujin, Kentaro, Hiroyuki Okada, Yoshifumi Iwamaru, et al.. (2011). Characterization of Syrian hamster adapted prions derived from L-type and C-type bovine spongiform encephalopathies. Prion. 5(2). 103–108. 14 indexed citations
5.
Imamura, Morikazu, Nobuko Kato, Hiroyuki Okada, et al.. (2011). Strain-specific effects of reducing agents on the cell-free conversion of recombinant prion protein into a protease-resistant form. Microbiology and Immunology. 55(9). 633–640. 1 indexed citations
6.
Imamura, Morikazu, Nobuko Kato, Miyako Yoshioka, et al.. (2011). Glycosylphosphatidylinositol Anchor-Dependent Stimulation Pathway Required for Generation of Baculovirus-Derived Recombinant Scrapie Prion Protein. Journal of Virology. 85(6). 2582–2588. 15 indexed citations
7.
Murayama, Yuichi, Miyako Yoshioka, Kentaro Masujin, et al.. (2010). Sulfated Dextrans Enhance In Vitro Amplification of Bovine Spongiform Encephalopathy PrPSc and Enable Ultrasensitive Detection of Bovine PrPSc. PLoS ONE. 5(10). e13152–e13152. 47 indexed citations
8.
Kobayashi, Atsushi, et al.. (2009). Heterozygous inhibition in prion infection. Prion. 3(1). 27–30. 13 indexed citations
9.
Fukuda, Shigeo, Yoshifumi Iwamaru, Morikazu Imamura, et al.. (2009). Intraspecies transmission of L‐type‐like bovine spongiform encephalopathy detected in Japan. Microbiology and Immunology. 53(12). 704–707. 36 indexed citations
10.
Iwamaru, Yoshifumi, Yoshihisa Shimizu, Morikazu Imamura, et al.. (2008). Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation. Journal of Neurochemistry. 107(3). 636–646. 33 indexed citations
11.
Yokoyama, Takashi, Kentaro Masujin, Yoshio Yamakawa, et al.. (2007). Experimental Transmission of Two Young and One Suspended Bovine Spongiform Encephalopathy (BSE) Cases to Bovinized Transgenic Mice. Japanese Journal of Infectious Diseases. 60(5). 317–320. 14 indexed citations
12.
Suyama, Kyozo, Miyako Yoshioka, Mitsugu Akagawa, et al.. (2007). Assessment of Prion Inactivation by Fenton Reaction Using Protein Misfolding Cyclic Amplification and Bioassay. Bioscience Biotechnology and Biochemistry. 71(8). 2069–2071. 10 indexed citations
13.
Asano, Masahiro, Shirou Mohri, James W. Ironside, et al.. (2006). vCJD prion acquires altered virulence through trans-species infection. Biochemical and Biophysical Research Communications. 342(1). 293–299. 48 indexed citations
14.
Murayama, Yuichi, Miyako Yoshioka, Masuhiro Takata, et al.. (2006). Protein misfolding cyclic amplification as a rapid test for assessment of prion inactivation. Biochemical and Biophysical Research Communications. 348(2). 758–762. 28 indexed citations
15.
Kobayashi, Atsushi, et al.. (2004). Type 1 and type 2 human PrPSc have different aggregation sizes in methionine homozygotes with sporadic, iatrogenic and variant Creutzfeldt–Jakob disease. Journal of General Virology. 86(1). 237–240. 15 indexed citations
16.
Nakamura, Naoto, Mariko Shimokawa, Shirou Mohri, et al.. (2003). Generation of Antibodies Against Prion Protein by Scrapie-Infected Cell Immunization of PrP 0/0 Mice. PubMed. 22(4). 263–266. 13 indexed citations
17.
Matsuda, Haruo, et al.. (1999). A chicken monoclonal antibody with specificity for the N-terminal of human prion protein. FEMS Immunology & Medical Microbiology. 23(3). 189–194. 51 indexed citations
18.
Yum, Seungshic, Toshio Takahashi, Osamu Koizumi, et al.. (1998). A Novel Neuropeptide, Hym-176, Induces Contraction of the Ectodermal Muscle in Hydra. Biochemical and Biophysical Research Communications. 248(3). 584–590. 63 indexed citations
19.
Mori, Ryoichi, et al.. (1990). Herpes Simplex Virus Type 1 Infection in Mice with Severe Combined Immunodeficiency (SCID). Advances in experimental medicine and biology. 278. 191–197. 9 indexed citations
20.
Morita, Çhiharu, et al.. (1989). SPOTTED FEVER GROUP RICKETTSIA IN DOGS IN JAPAN. Japanese Journal of Medical Science and Biology. 42(4). 143–147. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suehiro Sakaguchi Breakdown of academic impact, for papers by Lorenzo González Breakdown of academic impact, for papers by Moira E. Bruce Breakdown of academic impact, for papers by Mark D. Zabel Breakdown of academic impact, for papers by H. Diringer Breakdown of academic impact, for papers by Richard F. Marsh Breakdown of academic impact, for papers by Michael B. Coulthart Breakdown of academic impact, for papers by Peter C. Hoppe Breakdown of academic impact, for papers by Richard S. Stewart Breakdown of academic impact, for papers by R.H. Kimberlin
Rankless by CCL
2026